Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by abnormal phosphorus metabolism, resulting from the secretion of fibroblast growth factor 23 (FGF23) by small mesenchymal tumors [1-5]. The gene discussed is FGF23; the disease is mesenchymal cell neoplasm.